plus just announced first downstream commercialization is hardly backwatered.
"Scorpion Biological Services, a subsidiary of Heat Biologics, Inc., is building a new 500,000 square foot biomanufacturing facility in Manhattan, Kansas. The $650 million project is expected to create 500 jobs over the next seven years."
https://www.areadevelopment.com/newsItems/4-21-2022/scorpion-biological-services-manhattan-kansas.shtml